Cargando…

Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed

In this retrospective study, we investigated whether the kinetic change of serum carcinoembryonic antigen (CEA) levels can be an early indicator for the progression in metastatic non-small cell lung cancer (NSCLC) patients during maintenance therapy with bevacizumab plus pemetrexed. Ten patients dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasha, Zhang, Li, Kong, Fang, Shi, Wang, Jing, Haiyong, Wang, Ming, Yang, Jinming, Yu, Hui, Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650388/ https://www.ncbi.nlm.nih.gov/pubmed/29088833 http://dx.doi.org/10.18632/oncotarget.20456

Ejemplares similares

Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed
por: Zhang, Nasha, et al.
Publicado: (2017)

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
por: Wang, Haiyong, et al.
Publicado: (2016)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
por: Prager, Gerald W, et al.
Publicado: (2014)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)

Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972)

Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion
por: Chen, Dawei, et al.
Publicado: (2016)

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression
por: Cardona, Andrés Felipe, et al.
Publicado: (2016)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
por: Tsutani, Yasuhiro, et al.
Publicado: (2018)

The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.
por: Cooper, E. H., et al.
Publicado: (1975)

Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
por: Aldilaijan, Abdulmohsin Fawzi, et al.
Publicado: (2023)

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321
por: Kasai, Takashi, et al.
Publicado: (2023)

Proceedings: Use of the carcinoembryonic antigen and serum enzyme changes in the detection of metastatic involvement of the liver.
por: Steele, L., et al.
Publicado: (1974)

Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
por: Anoop, Thattungal Manoharan, et al.
Publicado: (2022)

The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015)

On-Site Detection of Carcinoembryonic Antigen in Human Serum
por: Mahmoudi, Tohid, et al.
Publicado: (2021)

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
por: Zinner, Ralph G., et al.
Publicado: (2015)

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013)

Carcinoembryonic Antigen Level Can be Overestimated in Metabolic Syndrome
por: Kim, Kyu-Nam, et al.
Publicado: (2011)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
por: Lin, Zhong, et al.
Publicado: (2017)

Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
por: Tian, Yaru, et al.
Publicado: (2019)

Serum Carcinoembryonic Antigen for Recurrence in Colorectal Cancer Patients
por: Kim, Young Jin
Publicado: (2013)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
por: Schuette, Wolfgang, et al.
Publicado: (2017)

Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
por: Zhao, Xinmin, et al.
Publicado: (2017)

Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer
por: Ma, Yunfeng, et al.
Publicado: (2022)

Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland
por: Barbier, Michaela Carla, et al.
Publicado: (2023)

MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab
por: Jing, Wang, et al.
Publicado: (2020)

Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)

Carcinoembryonic antigen in hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1978)

Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
por: Kang, Jae Seung, et al.
Publicado: (2021)

A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
por: Cho, Byoung Chul, et al.
Publicado: (2005)

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
por: Zhang, Bin, et al.
Publicado: (2016)

Factors Associated with Serum Levels of Carcinoembryonic Antigen in Healthy Non-smokers
por: No, Jung-Im, et al.
Publicado: (2013)

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
por: Wei, Po-Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kdaccdmdbbih5furoh7o0sm0g6